CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | chalcogen oxoanion |
|
Accession: | CHEBI:33485
|
browse the term
|
Synonyms: | related_synonym: | chalcogen oxoanions |
|
|
|
G |
Alb |
albumin |
affects binding |
ISO |
chromotrope 2R binds to ALB protein |
CTD |
PMID:19347248 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
multiple interactions |
ISO |
Benzenesulfonates analog inhibits the reaction [SLC10A1 protein results in increased transport of Taurocholic Acid] |
CTD |
PMID:22641618 |
|
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
brilliant green results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:26177467 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
brilliant green results in increased cleavage of and results in increased activity of CASP7 protein |
CTD |
PMID:26177467 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
brilliant green results in decreased expression of CCND1 protein |
CTD |
PMID:26177467 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ikbke |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
decreases expression |
ISO |
brilliant green results in decreased expression of IKBKE protein |
CTD |
PMID:26177467 |
|
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
|
|
G |
Lonp1 |
lon peptidase 1, mitochondrial |
increases expression |
ISO |
brilliant green results in increased expression of LONP1 mRNA |
CTD |
PMID:21215310 |
|
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
brilliant green inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Txn1 |
thioredoxin 1 |
increases oxidation |
ISO |
brilliant green results in increased oxidation of TXN protein |
CTD |
PMID:21215310 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txn2 |
thioredoxin 2 |
decreases expression affects response to substance multiple interactions |
ISO |
brilliant green results in decreased expression of TXN2 protein TXN2 protein affects the susceptibility to brilliant green brilliant green results in increased oxidation of and results in increased degradation of TXN2 protein |
CTD |
PMID:21215310 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions affects binding |
EXP ISO |
Congo Red inhibits the reaction [APP protein binds to APP protein] Congo Red binds to APP protein |
CTD |
PMID:17323972 PMID:17406451 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Prnp |
prion protein |
decreases expression |
ISO |
Congo Red results in decreased expression of PRNP protein alternative form |
CTD |
PMID:11994310 |
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
|
G |
Ache |
acetylcholinesterase |
increases activity |
ISO |
Dithionite results in increased activity of ACHE protein |
CTD |
PMID:33617922 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
decreases activity multiple interactions |
EXP |
Dithionite results in decreased activity of ACP5 protein ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein] |
CTD |
PMID:6886379 |
|
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; [Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:21803128 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP ISO |
[Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein] dihydroactinidiolide inhibits the reaction [Dithionite results in increased expression of BAX protein] |
CTD |
PMID:21803128 PMID:33617922 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; [Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein] dihydroactinidiolide inhibits the reaction [Dithionite results in decreased expression of BCL2 protein] |
CTD |
PMID:21803128 PMID:33617922 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
C5 |
complement C5 |
multiple interactions |
ISO |
Dithionite inhibits the reaction [Asbestos, Crocidolite results in increased cleavage of C5 protein]; Dithionite inhibits the reaction [Asbestos, Serpentine results in increased cleavage of C5 protein] |
CTD |
PMID:10777245 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity |
EXP ISO |
[Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; [Dithionite co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form; MIR205 mRNA inhibits the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form] Dithionite results in increased expression of CASP3 protein Dithionite results in increased activity of CASP3 protein |
CTD |
PMID:21803128 PMID:33617922 PMID:34078833 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions |
ISO |
[[Dithionite results in increased reduction of Paraquat] which co-treated with SLC6A3 protein] results in increased expression of DNM1L protein; [Dithionite results in increased reduction of Paraquat] which results in increased expression of DNM1L protein |
CTD |
PMID:35511227 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
multiple interactions |
EXP |
[Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein; Genistein inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein] |
CTD |
PMID:27238724 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
[dihydroactinidiolide co-treated with Dithionite] results in increased expression of HMOX1 mRNA |
CTD |
PMID:33617922 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Mir205 |
microRNA 205 |
multiple interactions |
EXP |
[Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; [Oxygen co-treated with Dithionite] results in increased expression of MIR205 mRNA; MIR205 mRNA inhibits the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of MIR205 mRNA] |
CTD |
PMID:34078833 |
|
NCBI chr13:105,035,878...105,035,985
Ensembl chr13:105,035,878...105,035,985
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
[dihydroactinidiolide co-treated with Dithionite] results in increased expression of NFE2L2 mRNA |
CTD |
PMID:33617922 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Pink1 |
PTEN induced kinase 1 |
multiple interactions |
EXP |
[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein] |
CTD |
PMID:34078833 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
multiple interactions |
ISO |
[[Dithionite results in increased reduction of Paraquat] which co-treated with SLC6A3 protein] results in increased expression of DNM1L protein |
CTD |
PMID:35511227 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
Fast Green FCF inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
EXP |
glucoerucin results in increased expression of CYP1A1 protein |
CTD |
PMID:20833222 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
EXP |
glucoerucin results in increased expression of CYP1A2 protein |
CTD |
PMID:20833222 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
EXP |
glucoerucin results in increased expression of CYP1B1 protein |
CTD |
PMID:20833222 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
glucoerucin results in increased expression of EPHX1 protein |
CTD |
PMID:21132492 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity |
EXP |
glucoerucin results in increased activity of NQO1 protein |
CTD |
PMID:20833222 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions affects binding |
ISO |
Indigo Carmine binds to and results in increased activity of AHR protein Indigo Carmine binds to AHR protein |
CTD |
PMID:11425848 PMID:15001395 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
EXP |
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of CHRNA4 protein |
CTD |
PMID:23429044 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
EXP |
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of CHRNB2 protein |
CTD |
PMID:23429044 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity increases expression multiple interactions |
ISO EXP |
Indigo Carmine results in increased activity of CYP1A1 protein Indigo Carmine results in increased expression of CYP1A1 mRNA Indigo Carmine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] |
CTD |
PMID:15001395 PMID:15882963 PMID:18493746 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
multiple interactions |
EXP |
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein |
CTD |
PMID:23429044 |
|
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions decreases activity |
ISO |
Indocyanine Green inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Indocyanine Green results in decreased activity of ABCB11 protein |
CTD |
PMID:24014644 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
affects export |
ISO |
ABCB4 protein affects the export of Indocyanine Green |
CTD |
PMID:11302927 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Indocyanine Green results in increased expression of BAX mRNA; Indocyanine Green results in increased expression of BAX protein |
CTD |
PMID:23675521 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
Indocyanine Green results in increased expression of CASP9 mRNA; Indocyanine Green results in increased expression of CASP9 protein |
CTD |
PMID:23675521 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
increases uptake multiple interactions |
ISO |
SLC10A1 protein results in increased uptake of Indocyanine Green Nifedipine promotes the reaction [SLC10A1 protein results in increased uptake of Indocyanine Green]; Taurocholic Acid inhibits the reaction [SLC10A1 protein results in increased uptake of Indocyanine Green] |
CTD |
PMID:32209977 |
|
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Slc10a2 |
solute carrier family 10 member 2 |
increases uptake |
ISO |
SLC10A2 protein results in increased uptake of Indocyanine Green |
CTD |
PMID:32209977 |
|
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
|
|
G |
Slc16a2 |
solute carrier family 16 member 2 |
multiple interactions |
ISO |
Indocyanine Green inhibits the reaction [SLC16A2 protein results in increased uptake of Triiodothyronine] |
CTD |
PMID:28119167 |
|
NCBI chr X:68,725,365...68,848,572
Ensembl chr X:68,723,261...68,848,771
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
multiple interactions |
ISO |
Indocyanine Green inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates] |
CTD |
PMID:12065749 |
|
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
multiple interactions |
EXP |
Indocyanine Green inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] |
CTD |
PMID:10224140 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions increases uptake increases transport |
ISO |
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [ABCG2 protein results in increased uptake of lucifer yellow]; Novobiocin inhibits the reaction [ABCG2 protein results in increased uptake of lucifer yellow]; Omeprazole inhibits the reaction [ABCG2 protein results in increased transport of lucifer yellow] |
CTD |
PMID:31348918 PMID:32305507 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions |
EXP |
Dipyrone inhibits the reaction [IL1B protein results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [IL6 protein results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [Lipopolysaccharides results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [TNF protein results in increased secretion of CRH protein] |
CTD |
PMID:11852909 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
EXP |
Dipyrone promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein] |
CTD |
PMID:15309881 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Dipyrone inhibits the reaction [IL1B protein results in increased secretion of CRH protein] |
CTD |
PMID:11852909 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Dipyrone inhibits the reaction [IL6 protein results in increased secretion of CRH protein] |
CTD |
PMID:11852909 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
decreases activity |
ISO |
Dipyrone analog results in decreased activity of PTGS1 protein; Dipyrone results in decreased activity of PTGS1 protein |
CTD |
PMID:12242329 PMID:16141368 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Tgfa |
transforming growth factor alpha |
multiple interactions |
EXP |
Dipyrone promotes the reaction [Hydrochloric Acid results in increased expression of TGFA protein] |
CTD |
PMID:15309881 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
Dipyrone inhibits the reaction [TNF protein results in increased secretion of CRH protein] |
CTD |
PMID:11852909 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases activity increases expression affects oxidation multiple interactions |
ISO |
potassium tellurate(IV) results in increased activity of TXNRD1 protein potassium tellurate(IV) results in increased expression of TXNRD1 mRNA potassium tellurate(IV) affects the oxidation of TXNRD1 protein potassium tellurate(IV) promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein] |
CTD |
PMID:19486940 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
increases activity |
ISO |
potassium tellurate(IV) results in increased activity of TXNRD2 protein |
CTD |
PMID:19486940 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
Direct Red 81 inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
|
|
|
G |
Abcc9 |
ATP binding cassette subfamily C member 9 |
increases expression |
EXP |
sodium metabisulfite results in increased expression of ABCC9 mRNA; sodium metabisulfite results in increased expression of ABCC9 protein |
CTD |
PMID:25463229 PMID:26015265 |
|
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
sodium metabisulfite results in increased expression of BAX mRNA |
CTD |
PMID:33957602 PMID:35067933 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
sodium metabisulfite results in decreased expression of BCL2 mRNA |
CTD |
PMID:33957602 PMID:35067933 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
decreases expression |
EXP |
sodium metabisulfite results in decreased expression of CACNA1C mRNA; sodium metabisulfite results in decreased expression of CACNA1C protein |
CTD |
PMID:25463229 PMID:26015265 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
decreases expression |
EXP |
sodium metabisulfite results in decreased expression of CACNA1D mRNA; sodium metabisulfite results in decreased expression of CACNA1D protein |
CTD |
PMID:25463229 PMID:26015265 |
|
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
EXP ISO |
GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP3 protein] sodium metabisulfite results in increased expression of and results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:25486021 PMID:33957602 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases expression multiple interactions increases activity |
ISO EXP |
sodium metabisulfite results in increased expression of CASP8 mRNA GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP8 protein] |
CTD |
PMID:25486021 PMID:33957602 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases expression multiple interactions increases activity |
ISO EXP |
sodium metabisulfite results in increased expression of CASP9 mRNA GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP9 protein] |
CTD |
PMID:25486021 PMID:33957602 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
EXP |
sodium metabisulfite results in increased expression of DDIT3 protein |
CTD |
PMID:25486021 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
multiple interactions |
EXP |
GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP3 protein]; GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP8 protein]; GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP9 protein]; GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of XDH protein] |
CTD |
PMID:25486021 |
|
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
EXP |
sodium metabisulfite results in increased expression of HSPA5 protein |
CTD |
PMID:25486021 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Kcnj11 |
potassium inwardly-rectifying channel, subfamily J, member 11 |
increases expression |
EXP |
sodium metabisulfite results in increased expression of KCNJ11 mRNA; sodium metabisulfite results in increased expression of KCNJ11 protein |
CTD |
PMID:25463229 PMID:26015265 |
|
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
|
|
G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
increases expression |
EXP |
sodium metabisulfite results in increased expression of KCNJ8 mRNA; sodium metabisulfite results in increased expression of KCNJ8 protein |
CTD |
PMID:25463229 |
|
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
increases expression |
EXP |
sodium metabisulfite results in increased expression of KCNMA1 mRNA; sodium metabisulfite results in increased expression of KCNMA1 protein |
CTD |
PMID:25463229 |
|
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
|
|
G |
Kcnmb1 |
potassium calcium-activated channel subfamily M regulatory beta subunit 1 |
increases expression |
EXP |
sodium metabisulfite results in increased expression of KCNMB1 mRNA; sodium metabisulfite results in increased expression of KCNMB1 protein |
CTD |
PMID:25463229 |
|
NCBI chr10:18,557,510...18,614,824
Ensembl chr10:18,557,904...18,565,798
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression |
ISO |
sodium metabisulfite results in decreased expression of NFKB1 mRNA |
CTD |
PMID:35067933 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases phosphorylation |
EXP |
sodium metabisulfite results in increased phosphorylation of RELA protein |
CTD |
PMID:25486021 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Scn1a |
sodium voltage-gated channel alpha subunit 1 |
increases expression |
EXP |
sodium metabisulfite results in increased expression of SCN1A protein |
CTD |
PMID:29188487 |
|
NCBI chr 3:50,952,790...51,071,804
Ensembl chr 3:50,952,791...51,071,699
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression |
ISO |
sodium metabisulfite results in decreased expression of TP53 mRNA |
CTD |
PMID:35067933 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions increases activity |
EXP |
GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of XDH protein] |
CTD |
PMID:25486021 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Aadacl2 |
arylacetamide deacetylase-like 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of AADACL2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:144,123,557...144,144,159
|
|
G |
Abca12 |
ATP binding cassette subfamily A member 12 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ABCA12 mRNA |
CTD |
PMID:25377654 |
|
NCBI chr 9:72,822,661...72,995,748
Ensembl chr 9:72,823,350...72,996,049
|
|
G |
Abca6 |
ATP binding cassette subfamily A member 6 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ABCA6 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr10:95,142,805...95,212,087
Ensembl chr10:95,142,966...95,211,530
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ABCB6 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions |
ISO |
Sodium Dodecyl Sulfate inhibits the reaction [ABCC1 protein results in increased export of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein] |
CTD |
PMID:16101123 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ABCC2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ABCC3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
affects response to substance |
ISO |
ACACB SNP affects the susceptibility to Sodium Dodecyl Sulfate |
CTD |
PMID:27206134 |
|
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ACKR3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Adamts3 |
ADAM metallopeptidase with thrombospondin type 1, motif 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ADAMTS3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr14:18,231,128...18,437,771
Ensembl chr14:18,231,165...18,435,556
|
|
G |
Adap2 |
ArfGAP with dual PH domains 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ADAP2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
|
|
G |
Adgre5 |
adhesion G protein-coupled receptor E5 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ADGRE5 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:24,397,972...24,418,648
Ensembl chr19:24,398,689...24,418,638
|
|
G |
Adgrg2 |
adhesion G protein-coupled receptor G2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ADGRG2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ADRB2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Adss2 |
adenylosuccinate synthase 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ADSS2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604
|
|
G |
Ahr |
aryl hydrocarbon receptor |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of AHR mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
affects response to substance |
ISO |
AIF1 SNP affects the susceptibility to Sodium Dodecyl Sulfate |
CTD |
PMID:27258892 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Ak8 |
adenylate kinase 8 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of AK8 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:12,028,895...12,144,468
Ensembl chr 3:12,028,954...12,144,465
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of AKR1B1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of AKR1B10 mRNA |
CTD |
PMID:20566472 PMID:30806763 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of AKR1C1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression decreases expression |
ISO EXP |
Sodium Dodecyl Sulfate results in increased expression of AKR1C3 mRNA Sodium Dodecyl Sulfate results in decreased expression of AKR1C3 mRNA Sodium Dodecyl Sulfate results in decreased expression of AKR1C18 mRNA |
CTD |
PMID:12815608 PMID:20566472 PMID:31734321 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation |
ISO |
Sodium Dodecyl Sulfate results in increased phosphorylation of AKT1 protein |
CTD |
PMID:23445166 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh3b2 |
aldehyde dehydrogenase 3 family, member B2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ALDH3B2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:201,250,260...201,264,699
Ensembl chr 1:201,253,157...201,264,705
|
|
G |
Aldh3b3 |
aldehyde dehydrogenase 3 family, member B3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ALDH3B2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:201,187,962...201,250,204
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ALOX5AP mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd50 |
ankyrin repeat domain containing 50 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ANKRD50 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:121,466,275...121,500,758
Ensembl chr 2:121,468,573...121,500,752
|
|
G |
Ap4s1 |
adaptor related protein complex 4 subunit sigma 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of AP4S1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:69,133,403...69,174,488
Ensembl chr 6:69,133,373...69,175,496
|
|
G |
Areg |
amphiregulin |
increases secretion |
ISO |
Sodium Dodecyl Sulfate results in increased secretion of AREG protein |
CTD |
PMID:17763283 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arfgap2 |
ADP-ribosylation factor GTPase activating protein 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ARFGAP2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:77,236,305...77,248,445
Ensembl chr 3:77,236,322...77,248,455
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ARHGDIB mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Art3 |
ADP-ribosyltransferase 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ART3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ASNS mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Aspm |
assembly factor for spindle microtubules |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ASPM mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ASXL1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ATF3 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atg9b |
autophagy related 9B |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ATG9B mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:10,784,934...10,793,832
Ensembl chr 4:10,786,114...10,793,651
|
|
G |
Atp12a |
ATPase H+/K+ transporting non-gastric alpha2 subunit |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ATP12A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ATP5PD protein |
CTD |
PMID:21469165 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
B3gat2 |
beta-1,3-glucuronyltransferase 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of B3GAT2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:26,167,174...26,250,153
Ensembl chr 9:26,167,174...26,250,153
|
|
G |
B3gnt3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of B3GNT3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr16:18,401,405...18,410,821
Ensembl chr16:18,401,405...18,410,766
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of BAMBI mRNA |
CTD |
PMID:20146380 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Bche |
butyrylcholinesterase |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of BCHE mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bicd1 |
BICD cargo adaptor 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of BICD1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:182,479,071...182,627,434
|
|
G |
Blvra |
biliverdin reductase A |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of BLVRA protein |
CTD |
PMID:21469165 |
|
NCBI chr 3:114,340,778...114,366,048
Ensembl chr 3:114,340,838...114,366,033
|
|
G |
Blvrb |
biliverdin reductase B |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of BLVRB mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Brinp1 |
BMP/retinoic acid inducible neural specific 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of BRINP1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:82,348,501...82,550,506
Ensembl chr 5:82,348,930...82,493,150
|
|
G |
C18h18orf21 |
similar to human chromosome 18 open reading frame 21 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of C18ORF21 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr18:15,779,349...15,786,772
Ensembl chr18:15,779,368...15,787,894
|
|
G |
C19h16orf46 |
similar to human chromosome 16 open reading frame 46 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of C16ORF46 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:45,017,499...45,033,453
Ensembl chr19:45,022,280...45,032,683
|
|
G |
C1r |
complement C1r |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of C1R mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
|
|
G |
C2 |
complement C2 |
affects response to substance |
ISO |
C2 SNP affects the susceptibility to Sodium Dodecyl Sulfate |
CTD |
PMID:27258892 |
|
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
|
|
G |
C2h5orf34 |
similar to human chromosome 5 open reading frame 34 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of C5ORF34 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:51,553,223...51,577,090
Ensembl chr 2:51,555,432...51,577,085
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CAMK2N1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Cant1 |
calcium activated nucleotidase 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CANT1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:103,637,079...103,650,240
Ensembl chr10:103,531,504...103,650,109
|
|
G |
Capns2 |
calpain, small subunit 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CAPNS2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:14,104,334...14,105,276
|
|
G |
Car2 |
carbonic anhydrase 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CA2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Cbll1 |
Cbl proto-oncogene like 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CBLL1 mRNA |
CTD |
PMID:21621594 |
|
NCBI chr 6:48,071,190...48,086,174
Ensembl chr 6:48,071,190...48,086,444
|
|
G |
Ccdc8 |
coiled-coil domain containing 8 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CCDC8 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:77,679,521...77,682,849
Ensembl chr 1:77,679,218...77,683,090
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CCL2 mRNA Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein] |
CTD |
PMID:20713136 PMID:36416909 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
multiple interactions increases expression increases secretion |
ISO |
IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein] Sodium Dodecyl Sulfate results in increased expression of CCL20 mRNA |
CTD |
PMID:15679580 PMID:30806763 PMID:31734321 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl27 |
C-C motif chemokine ligand 27 |
increases secretion |
ISO |
Sodium Dodecyl Sulfate results in increased secretion of CCL27 protein |
CTD |
PMID:15679580 |
|
NCBI chr 5:56,941,402...56,948,511
Ensembl chr 5:56,941,402...56,948,506
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein] |
CTD |
PMID:36416909 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CCL4 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases secretion increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased secretion of CCL5 protein Sodium Dodecyl Sulfate results in increased expression of CCL5 mRNA |
CTD |
PMID:16099135 PMID:31734321 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CCN1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression increases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CCN2 mRNA Sodium Dodecyl Sulfate results in increased expression of CCN2 mRNA |
CTD |
PMID:25377654 PMID:31734321 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CCR5 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CCR7 mRNA |
CTD |
PMID:19371601 |
|
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Cd40 |
CD40 molecule |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CD40 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CD86 protein |
CTD |
PMID:19665512 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdc25a |
cell division cycle 25A |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CDC25A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdh26 |
cadherin 26 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CDH26 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:165,520,523...165,573,191
Ensembl chr 3:165,520,439...165,572,149
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CDKN1C mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Celf6 |
CUGBP, Elav-like family member 6 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CELF6 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:59,975,095...60,006,060
Ensembl chr 8:59,975,088...60,005,041
|
|
G |
Cerk |
ceramide kinase |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CERK mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:117,225,855...117,269,436
Ensembl chr 7:117,225,855...117,268,759
|
|
G |
Cers3 |
ceramide synthase 3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CERS3 mRNA |
CTD |
PMID:29155129 PMID:31734321 |
|
NCBI chr 1:120,316,930...120,422,926
Ensembl chr 1:120,318,212...120,422,902
|
|
G |
Cfl1 |
cofilin 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CFL1 mRNA; Sodium Dodecyl Sulfate results in increased expression of CFL1 protein |
CTD |
PMID:21469165 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CHAC1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chst11 |
carbohydrate sulfotransferase 11 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CHST11 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:20,524,535...20,743,008
Ensembl chr 7:20,528,100...20,743,111
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CITED2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CLCF1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Cldn7 |
claudin 7 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CLDN7 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
|
|
G |
Clk3 |
CDC-like kinase 3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CLK3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:58,152,155...58,167,196
Ensembl chr 8:58,152,155...58,168,181
|
|
G |
Clmn |
calmin |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CLMN mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:123,707,710...123,807,283
Ensembl chr 6:123,713,507...123,807,272
|
|
G |
Cmklr2 |
chemerin chemokine-like receptor 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CMKLR2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:64,583,310...64,617,883
Ensembl chr 9:64,585,594...64,586,655
|
|
G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CMTM8 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:114,481,730...114,547,107
Ensembl chr 8:114,481,982...114,547,083
|
|
G |
Cnfn |
cornifelin |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CNFN mRNA; Sodium Dodecyl Sulfate results in increased expression of CNFN protein |
CTD |
PMID:25377654 |
|
NCBI chr 1:80,949,699...80,953,747
Ensembl chr 1:80,951,600...80,953,747
|
|
G |
Cnnm2 |
cyclin and CBS domain divalent metal cation transport mediator 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CNNM2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:245,643,682...245,769,542
Ensembl chr 1:245,643,768...245,763,286
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of COL11A1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of COL2A1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Cox19 |
cytochrome c oxidase assembly factor COX19 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of COX19 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:15,303,535...15,313,014
Ensembl chr12:15,303,551...15,313,014
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CPT1A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CRABP2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
|
|
G |
Crct1 |
cysteine-rich C-terminal 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CRCT1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:178,633,789...178,635,274
Ensembl chr 2:178,634,092...178,634,394
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CREB1 mRNA |
CTD |
PMID:20385217 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CREBBP mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CRELD2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
|
|
G |
Crnn |
cornulin |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CRNN mRNA |
CTD |
PMID:25240866 |
|
NCBI chr 2:178,733,329...178,736,404
Ensembl chr 2:178,731,796...178,736,216
|
|
G |
Crtam |
cytotoxic and regulatory T cell molecule |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CRTAM mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:41,340,117...41,377,381
Ensembl chr 8:41,340,837...41,377,343
|
|
G |
Csf2 |
colony stimulating factor 2 |
increases expression increases secretion |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CSF2 mRNA Sodium Dodecyl Sulfate results in increased secretion of CSF2 protein |
CTD |
PMID:11378323 PMID:22245253 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf2rb |
colony stimulating factor 2 receptor subunit beta |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CSF2RB mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CSRNP1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Ctdnep1 |
CTD nuclear envelope phosphatase 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CTDNEP1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:54,704,367...54,713,781
Ensembl chr10:54,704,148...54,713,781
|
|
G |
Ctsh |
cathepsin H |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CTSH mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:90,608,941...90,627,824
|
|
G |
Cul7 |
cullin 7 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CUL7 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:14,319,102...14,333,035
Ensembl chr 9:14,319,108...14,332,741
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CXCL1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CXCL10 mRNA |
CTD |
PMID:17936526 PMID:23445166 PMID:31734321 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
decreases expression multiple interactions |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CXCL14 mRNA; Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein]; WHI P131 inhibits the reaction [Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein] |
CTD |
PMID:31734321 |
|
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
decreases expression increases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CXCL2 protein Sodium Dodecyl Sulfate results in increased expression of CXCL2 protein |
CTD |
PMID:23178550 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CXCL1 mRNA |
CTD |
PMID:28826779 PMID:31734321 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CXCR4 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyb561a3 |
cytochrome b561 family, member A3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CYB561A3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:207,216,185...207,237,575
Ensembl chr 1:207,226,230...207,237,571
|
|
G |
Cyb5r4 |
cytochrome b5 reductase 4 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CYB5R4 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:87,975,596...88,048,356
Ensembl chr 8:87,981,116...88,045,832
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of CYP1A1 mRNA |
CTD |
PMID:20491607 PMID:30806763 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Sodium Dodecyl Sulfate results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
decreases expression |
EXP |
Sodium Dodecyl Sulfate results in decreased expression of CYP2B2 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp4f1 |
cytochrome P450, family 4, subfamily f, polypeptide 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of CYP4F12 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
EXP |
Sodium Dodecyl Sulfate results in decreased expression of CYP51 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Dapl1 |
death associated protein-like 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of DAPL1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:43,960,993...43,980,940
Ensembl chr 3:43,960,810...43,980,940
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of DCXR mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of DDIT3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddx60 |
DEXD/H-box helicase 60 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of DDX60 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
|
|
G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of DEGS1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
|
|
G |
Dennd2d |
DENN domain containing 2D |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of DENND2D mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:193,973,231...193,992,275
Ensembl chr 2:193,973,231...193,992,270
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of DFFB mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
EXP |
Sodium Dodecyl Sulfate results in decreased expression of DHCR7 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhdh |
dihydrodiol dehydrogenase |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of DHDH mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:95,954,361...95,965,262
Ensembl chr 1:95,953,092...95,965,197
|
|
G |
Dip2c |
disco-interacting protein 2 homolog C |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of DIP2C mRNA |
CTD |
PMID:31734321 |
|
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of DNAJB4 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dok7 |
docking protein 7 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of DOK7 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr14:75,665,444...75,699,413
Ensembl chr14:75,666,744...75,699,386
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of DPYSL2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Dsc1 |
desmocollin 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of DSC1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
|
|
G |
Dsg1 |
desmoglein 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of DSG1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of DUSP1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp2 |
dual specificity phosphatase 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of DUSP2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
|
|
G |
E2f8 |
E2F transcription factor 8 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of E2F8 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of EDN1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Efemp2 |
EGF containing fibulin extracellular matrix protein 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of EFEMP2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of EGR1 mRNA |
CTD |
PMID:25377654 PMID:31734321 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of EIF2AK1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:10,710,771...10,744,597
Ensembl chr12:10,705,874...10,744,573
|
|
G |
Elovl1 |
ELOVL fatty acid elongase 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ELOVL1 mRNA |
CTD |
PMID:29155129 |
|
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of EMP1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Ermap |
erythroblast membrane associated protein (Scianna blood group) |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ERMAP mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:132,788,847...132,803,030
Ensembl chr 5:132,789,991...132,802,847
|
|
G |
Ezr |
ezrin |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of EZR mRNA; Sodium Dodecyl Sulfate results in increased expression of EZR protein |
CTD |
PMID:29893927 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F8 |
coagulation factor VIII |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of F8 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr18:140,848...172,330
Ensembl chr18:140,955...171,857
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of FABP3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of FABP4 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of FAH mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fam171a1 |
family with sequence similarity 171, member A1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of FAM171A1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr17:75,024,582...75,148,348
Ensembl chr17:75,024,575...75,150,255
|
|
G |
Fam83c |
family with sequence similarity 83, member C |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of FAM83C mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:144,333,736...144,339,758
Ensembl chr 3:144,332,982...144,339,802
|
|
G |
Fancl |
FA complementation group L |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of FANCL mRNA |
CTD |
PMID:31734321 |
|
NCBI chr14:100,249,733...100,317,958
Ensembl chr14:100,248,875...100,314,255
|
|
G |
Fbxo5 |
F-box protein 5 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of FBXO5 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fech |
ferrochelatase |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of FECH mRNA |
CTD |
PMID:20566472 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of FKBP11 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Flg |
filaggrin |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of FLG mRNA; Sodium Dodecyl Sulfate results in increased expression of FLG protein |
CTD |
PMID:25240866 |
|
NCBI chr 2:178,884,793...178,912,986
|
|
G |
Flg2 |
filaggrin 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of FLG2 mRNA |
CTD |
PMID:25240866 |
|
NCBI chr 2:178,789,792...178,802,232
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of FN1 mRNA |
CTD |
PMID:25377654 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression increases expression |
EXP ISO |
Sodium Dodecyl Sulfate results in decreased expression of FOS mRNA Sodium Dodecyl Sulfate results in increased expression of FOS mRNA |
CTD |
PMID:12815608 PMID:31734321 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxa2 |
forkhead box A2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of FOXA2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Foxn1 |
forkhead box N1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of FOXN1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:63,251,400...63,273,710
Ensembl chr10:63,251,400...63,273,710
|
|
G |
Foxo4 |
forkhead box O4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of FOXO4 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr X:66,385,241...66,392,115
Ensembl chr X:66,385,558...66,392,115
|
|
G |
Fst |
follistatin |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of FST mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of FTL mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
|
|
G |
Fzd7 |
frizzled class receptor 7 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of FZD7 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
G0s2 |
G0/G1switch 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of G0S2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of G6PD mRNA |
CTD |
PMID:20566472 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GADD45B mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gal |
galanin and GMAP prepropeptide |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GAL mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
decreases expression |
EXP |
Sodium Dodecyl Sulfate results in decreased expression of GAPDH mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gas2l3 |
growth arrest-specific 2 like 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GAS2L3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:23,803,578...23,836,816
Ensembl chr 7:23,806,310...23,836,411
|
|
G |
Gast |
gastrin |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GAST mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of GBP1 mRNA |
CTD |
PMID:21621594 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GCLC mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GCLM mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GEM mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of GJA1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of GJB1 mRNA |
CTD |
PMID:21621594 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
increases expression |
EXP |
Sodium Dodecyl Sulfate results in increased expression of GJB2 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gjb6 |
gap junction protein, beta 6 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of GJB6 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:31,284,561...31,294,552
Ensembl chr15:31,284,419...31,294,582
|
|
G |
Gjc1 |
gap junction protein, gamma 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GJC1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:87,758,192...87,785,443
Ensembl chr10:87,760,528...87,785,867
|
|
G |
Gldc |
glycine decarboxylase |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GLDC mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Gpatch11 |
G patch domain containing 11 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of GPATCH11 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:16,229,933...16,243,305
Ensembl chr 6:16,233,059...16,243,238
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GRB7 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Grhl1 |
grainyhead-like transcription factor 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of GRHL1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of GSR mRNA |
CTD |
PMID:20566472 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Has3 |
hyaluronan synthase 3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of HAS3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:34,768,421...34,782,170
Ensembl chr19:34,771,982...34,782,592
|
|
G |
Hcls1 |
hematopoietic cell specific Lyn substrate 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of HCLS1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr11:63,817,482...63,840,943
Ensembl chr11:63,817,476...63,841,014
|
|
G |
Herc6 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of HERC6 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744
|
|
G |
Hey1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of HEY1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
|
|
G |
Hist1h2af |
histone cluster 1 H2A family member F |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of H2AC8 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr17:41,379,404...41,379,796
Ensembl chr17:41,379,404...41,379,796
|
|
G |
Hist1h2bc |
histone cluster 1, H2bc |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of H2BC21 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642
|
|
G |
Hist2h2be |
histone cluster 2 H2B family member E |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of H2BC11 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:183,780,583...183,783,030
|
|
G |
Hk2 |
hexokinase 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of HK2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression affects expression |
ISO EXP |
Sodium Dodecyl Sulfate results in increased expression of HMOX1 mRNA Sodium Dodecyl Sulfate affects the expression of HMOX1 mRNA |
CTD |
PMID:12815608 PMID:20566472 PMID:22954530 PMID:30806763 PMID:31734321 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hmox2 |
heme oxygenase 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of HMOX2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
|
|
G |
Hnrnpab |
heterogeneous nuclear ribonucleoprotein A/B |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of HNRNPAB protein |
CTD |
PMID:21469165 |
|
NCBI chr10:35,857,040...35,862,935
Ensembl chr10:35,857,041...35,863,344
|
|
G |
Hnrnpll |
heterogeneous nuclear ribonucleoprotein L-like |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of HNRNPLL mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:14,969,953...15,000,574
Ensembl chr 6:14,970,057...14,999,745
|
|
G |
Hpcal1 |
hippocalcin-like 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of HPCAL1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:40,478,206...40,584,721
Ensembl chr 6:40,478,208...40,584,687
|
|
G |
Hs3st2 |
heparan sulfate-glucosamine 3-sulfotransferase 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of HS3ST2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:175,956,161...176,077,400
Ensembl chr 1:175,956,157...176,077,399
|
|
G |
Hscb |
HscB mitochondrial iron-sulfur cluster co-chaperone |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of HSCB mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:45,821,527...45,831,902
Ensembl chr12:45,821,555...45,831,909
|
|
G |
Hsfx3l |
heat shock transcription factor family, X-linked member 3 like |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of HSFX3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr X:146,126,163...146,128,629
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of HSPA6 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
decreases expression multiple interactions increases expression decreases phosphorylation |
EXP ISO |
Sodium Dodecyl Sulfate results in decreased expression of HSPB1 mRNA Sodium Dodecyl Sulfate results in decreased expression of and affects the localization of HSPB1 protein Sodium Dodecyl Sulfate results in increased expression of HSPB1 mRNA; Sodium Dodecyl Sulfate results in increased expression of HSPB1 protein Sodium Dodecyl Sulfate results in decreased phosphorylation of HSPB1 protein |
CTD |
PMID:12815608 PMID:20332019 PMID:21469165 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspb8 |
heat shock protein family B (small) member 8 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of HSPB8 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of HSPH1 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
|
|
G |
Ibtk |
inhibitor of Bruton tyrosine kinase |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of IBTK mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:86,625,591...86,698,661
Ensembl chr 8:86,625,597...86,698,260
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ICAM1 mRNA |
CTD |
PMID:11378323 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Idh3a |
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of IDH3A protein |
CTD |
PMID:21469165 |
|
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of IDI1 protein |
CTD |
PMID:21469165 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ifi35 |
interferon-induced protein 35 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of IFI35 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
|
|
G |
Ifng |
interferon gamma |
multiple interactions increases expression |
ISO |
[dibenzothiazyl disulfide co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein; [diethylamine co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein Sodium Dodecyl Sulfate results in increased expression of IFNG protein |
CTD |
PMID:12062936 PMID:28826779 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IGF2R mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein] |
CTD |
PMID:36416909 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IL13RA2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
|
|
G |
Il16 |
interleukin 16 |
increases secretion |
ISO |
Sodium Dodecyl Sulfate results in increased secretion of IL16 protein |
CTD |
PMID:30806763 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il17a |
interleukin 17A |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IL17A mRNA; Sodium Dodecyl Sulfate results in increased expression of IL17A protein |
CTD |
PMID:28826779 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions decreases expression increases expression increases secretion |
ISO |
IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein]; Sodium Dodecyl Sulfate results in increased expression of and results in increased secretion of IL1A protein Sodium Dodecyl Sulfate results in decreased expression of IL1A protein Sodium Dodecyl Sulfate results in increased expression of IL1A mRNA; Sodium Dodecyl Sulfate results in increased expression of IL1A protein Sodium Dodecyl Sulfate results in increased secretion of IL1A protein |
CTD |
PMID:11378323 PMID:12781210 PMID:15679580 PMID:19878710 PMID:21469165 PMID:25290854 PMID:33839235 More...
|
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IL1B mRNA |
CTD |
PMID:9856837 PMID:11378323 PMID:33715048 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IL1R2 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IL1RL1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il2 |
interleukin 2 |
multiple interactions increases expression |
ISO |
[Sodium Dodecyl Sulfate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 protein Sodium Dodecyl Sulfate results in increased expression of IL2 protein |
CTD |
PMID:15588918 PMID:22381623 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il24 |
interleukin 24 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IL24 protein |
CTD |
PMID:25168428 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il33 |
interleukin 33 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of IL33 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il36g |
interleukin 36, gamma |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IL36G mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480
|
|
G |
Il36rn |
interleukin 36 receptor antagonist |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IL36RN mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:7,044,419...7,051,016
Ensembl chr 3:7,044,406...7,051,016
|
|
G |
Il4 |
interleukin 4 |
multiple interactions increases expression |
ISO |
[dibenzothiazyl disulfide co-treated with Sodium Dodecyl Sulfate] results in increased expression of IL4 protein; [diethylamine co-treated with Sodium Dodecyl Sulfate] results in increased expression of IL4 protein Sodium Dodecyl Sulfate results in increased expression of IL4 mRNA |
CTD |
PMID:12062936 PMID:28826779 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IL6 mRNA; Sodium Dodecyl Sulfate results in increased expression of IL6 protein [Tetradecanoylphorbol Acetate co-treated with Sodium Dodecyl Sulfate] results in increased expression of and results in increased secretion of IL6 protein |
CTD |
PMID:11378323 PMID:24964617 PMID:33839235 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il7r |
interleukin 7 receptor |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IL7R mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Impdh2 |
inosine monophosphate dehydrogenase 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of IMPDH2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
|
|
G |
Irag1 |
inositol 1,4,5-triphosphate receptor associated 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IRAG1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:164,981,716...165,094,232
Ensembl chr 1:164,981,716...165,094,176
|
|
G |
Irx3 |
iroquois homeobox 3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of IRX3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:15,211,882...15,215,317
Ensembl chr19:15,211,878...15,215,317
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ITPR1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Ivl |
involucrin |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of IVL mRNA; Sodium Dodecyl Sulfate results in increased expression of IVL protein |
CTD |
PMID:25240866 |
|
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
Sodium Dodecyl Sulfate inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
|
|
G |
Jph2 |
junctophilin 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of JPH2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:151,994,768...152,058,941
Ensembl chr 3:151,994,778...152,058,904
|
|
G |
Jpx |
JPX transcript, XIST activator |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of JPX mRNA |
CTD |
PMID:31734321 |
|
NCBI chr X:68,511,491...68,665,132
|
|
G |
Jrk |
Jrk helix-turn-helix protein |
affects expression |
ISO |
Sodium Dodecyl Sulfate affects the expression of JRK mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:106,590,662...106,595,345
Ensembl chr 7:106,589,484...106,596,371
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of JUNB mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kctd11 |
potassium channel tetramerization domain containing 11 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of KCTD11 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:54,602,575...54,604,738
Ensembl chr10:54,599,754...54,604,760
|
|
G |
Kiaa1549 |
KIAA1549 homolog |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of KIAA1549 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:66,840,674...66,968,407
Ensembl chr 4:66,760,162...66,968,436
|
|
G |
Kiaa1958 |
KIAA1958 homolog |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of KIAA1958 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:74,491,762...74,637,929
Ensembl chr 5:74,491,752...74,632,408
|
|
G |
Kif20b |
kinesin family member 20B |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of KIF20B mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
|
|
G |
Klc2 |
kinesin light chain 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of KLC2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:202,414,555...202,424,787
Ensembl chr 1:202,414,557...202,424,672
|
|
G |
Klhl21 |
kelch-like family member 21 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of KLHL21 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:162,514,888...162,523,545
Ensembl chr 5:162,514,765...162,523,545
|
|
G |
Klk10 |
kallikrein related-peptidase 10 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of KLK10 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:94,234,536...94,239,369
Ensembl chr 1:94,235,096...94,239,376
|
|
G |
Klrg2 |
killer cell lectin like receptor G2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of KLRG2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:67,360,216...67,374,867
Ensembl chr 4:67,363,919...67,374,147
|
|
G |
Kng1 |
kininogen 1 |
increases expression |
EXP |
Sodium Dodecyl Sulfate results in increased expression of KNG1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Krt1 |
keratin 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of KRT1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
|
|
G |
Krt18 |
keratin 18 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of KRT18 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Krt2 |
keratin 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of KRT2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:132,940,879...132,948,031
Ensembl chr 7:132,940,862...132,947,963
|
|
G |
Krt8 |
keratin 8 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of KRT8 mRNA |
CTD |
PMID:21621594 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Krt80 |
keratin 80 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of KRT80 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:132,463,216...132,485,134
Ensembl chr 7:132,463,218...132,485,508
|
|
G |
Krt9 |
keratin 9 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of KRT9 protein |
CTD |
PMID:21469165 |
|
NCBI chr10:85,120,962...85,127,228
Ensembl chr10:85,122,424...85,127,228
|
|
G |
Lamb1 |
laminin subunit beta 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of LAMB1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
|
|
G |
Lamp3 |
lysosomal-associated membrane protein 3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of LAMP3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784
|
|
G |
Lce1e |
late cornified envelope 1E |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of LCE1E mRNA |
CTD |
PMID:25240866 |
|
NCBI chr 2:178,462,100...178,463,433
Ensembl chr 2:178,462,100...178,463,433
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of LCN2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Ldlrad3 |
low density lipoprotein receptor class A domain containing 3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of LDLRAD3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:88,239,529...88,481,340
Ensembl chr 3:88,239,622...88,481,267
|
|
G |
Lemd1 |
LEM domain containing 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of LEMD1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:43,631,705...43,697,765
Ensembl chr13:43,665,926...43,697,948
|
|
G |
Lias |
lipoic acid synthetase |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of LIAS mRNA |
CTD |
PMID:21621594 |
|
NCBI chr14:42,876,699...42,893,824
Ensembl chr14:42,876,699...42,893,783
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of LIF protein |
CTD |
PMID:19878710 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lig3 |
DNA ligase 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of LIG3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:67,717,808...67,741,141
Ensembl chr10:67,717,812...67,798,414
|
|
G |
LOC100912195 |
protein BEX1-like |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of BEX5 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:110,047,861...110,051,812
|
|
G |
Loricrin |
loricrin cornified envelope precursor protein |
decreases expression increases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of LORICRIN protein Sodium Dodecyl Sulfate results in increased expression of LORICRIN mRNA |
CTD |
PMID:25240866 PMID:33839235 |
|
NCBI chr 2:177,558,062...177,560,960
Ensembl chr 2:177,558,252...177,559,807
|
|
G |
Lrrc8e |
leucine rich repeat containing 8 VRAC subunit E |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of LRRC8E mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:2,578,240...2,589,407
Ensembl chr12:2,578,315...2,589,412
|
|
G |
Ltf |
lactotransferrin |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of LTF mRNA |
CTD |
PMID:21621594 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Lyn |
LYN proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of LYN mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
|
|
G |
Lypla1 |
lysophospholipase 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of LYPLA1 protein |
CTD |
PMID:21469165 |
|
NCBI chr 5:14,679,605...14,708,774
Ensembl chr 5:14,679,606...14,708,746
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MAFG mRNA |
CTD |
PMID:20566472 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Mageh1 |
MAGE family member H1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MAGEH1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr X:18,350,015...18,351,271
Ensembl chr X:18,349,774...18,351,516
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
decreases expression |
EXP |
Sodium Dodecyl Sulfate results in decreased expression of MAP3K1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MAP3K8 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:31734321 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
increases phosphorylation |
ISO |
Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK14 protein |
CTD |
PMID:15737199 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:31734321 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Marcksl1 |
MARCKS-like 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MARCKSL1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
|
|
G |
Mblac1 |
metallo-beta-lactamase domain containing 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MBLAC1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:17,071,465...17,072,736
Ensembl chr12:17,071,465...17,072,735
|
|
G |
Mctp1 |
multiple C2 and transmembrane domain containing 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MCTP1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:6,071,408...6,761,833
Ensembl chr 2:6,065,808...6,761,833
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ME1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Meox1 |
mesenchyme homeobox 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MEOX1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
|
|
G |
Micb |
MHC class I polypeptide-related sequence B |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MICB mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:78,495,779...78,513,030
Ensembl chr 1:78,495,779...78,512,827
|
|
G |
Mir205 |
microRNA 205 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of MIR205 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:105,035,878...105,035,985
Ensembl chr13:105,035,878...105,035,985
|
|
G |
Mmaa |
metabolism of cobalamin associated A |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MMAA mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:28,619,060...28,649,319
Ensembl chr19:28,619,087...28,649,319
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MMP10 mRNA |
CTD |
PMID:30806763 PMID:31734321 |
|
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MMP3 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mosmo |
modulator of smoothened |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of MOSMO mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:175,217,680...175,288,521
Ensembl chr 1:175,217,545...175,288,334
|
|
G |
Mrpl38 |
mitochondrial ribosomal protein L38 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of MRPL38 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:101,365,353...101,372,159
Ensembl chr10:101,365,353...101,372,171
|
|
G |
Msrb2 |
methionine sulfoxide reductase B2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of MSRB2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr17:81,974,378...82,000,044
Ensembl chr17:81,974,196...82,000,043
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MT1A mRNA |
CTD |
PMID:20491607 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MT2A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Muc15 |
mucin 15, cell surface associated |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of MUC15 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:97,294,728...97,308,641
Ensembl chr 3:97,294,783...97,307,090
|
|
G |
Mxd1 |
max dimerization protein 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MXD1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
EXP |
Sodium Dodecyl Sulfate results in increased expression of MYC mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myef2 |
myelin expression factor 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MYEF2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:112,338,241...112,374,122
Ensembl chr 3:112,338,241...112,374,181
|
|
G |
Myl12a |
myosin light chain 12A |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of MYL12A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:110,891,970...110,899,655
Ensembl chr 9:110,873,959...110,916,580
|
|
G |
Nexn |
nexilin (F actin binding protein) |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of NEXN mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:241,186,790...241,218,342
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
affects expression |
ISO |
Sodium Dodecyl Sulfate affects the expression of NFKB1 mRNA |
CTD |
PMID:20385217 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfya |
nuclear transcription factor Y subunit alpha |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of NFYA mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:12,587,437...12,613,911
Ensembl chr 9:12,586,259...12,613,898
|
|
G |
Nipsnap2 |
nipsnap homolog 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of NIPSNAP2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:26,906,068...26,944,201
Ensembl chr12:26,911,723...26,944,166
|
|
G |
Nlrp10 |
NLR family, pyrin domain containing 10 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of NLRP10 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:162,922,806...162,930,363
Ensembl chr 1:162,922,806...162,930,363
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of NME2 protein |
CTD |
PMID:21469165 |
|
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
|
|
G |
Nmu |
neuromedin U |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of NMU mRNA |
CTD |
PMID:31734321 |
|
NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of NQO1 mRNA |
CTD |
PMID:20491607 PMID:20566472 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of NR4A2 mRNA |
CTD |
PMID:25377654 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
affects response to substance |
ISO |
NTRK2 SNP affects the susceptibility to Sodium Dodecyl Sulfate |
CTD |
PMID:27206134 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Olfml2a |
olfactomedin-like 2A |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of OLFML2A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:22,688,590...22,717,917
Ensembl chr 3:22,688,598...22,717,909
|
|
G |
P2ry1 |
purinergic receptor P2Y1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of P2RY1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:145,241,975...145,248,186
Ensembl chr 2:145,241,849...145,248,457
|
|
G |
Pask |
PAS domain containing serine/threonine kinase |
decreases expression |
EXP |
Sodium Dodecyl Sulfate results in decreased expression of PASK mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111
|
|
G |
Pced1a |
PC-esterase domain containing 1A |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PCED1A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:117,600,958...117,622,992
Ensembl chr 3:117,616,921...117,622,962
|
|
G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PCK2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
|
|
G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PCSK6 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:119,428,978...119,627,626
Ensembl chr 1:119,429,265...119,627,596
|
|
G |
Pctp |
phosphatidylcholine transfer protein |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PCTP mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:74,808,887...74,856,260
Ensembl chr10:74,808,887...74,849,867
|
|
G |
Pdha1 |
pyruvate dehydrogenase E1 subunit alpha 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PDHA1 protein |
CTD |
PMID:21469165 |
|
NCBI chr X:34,700,481...34,714,309
Ensembl chr X:34,700,409...34,714,311
|
|
G |
Per2 |
period circadian regulator 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PER2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
|
|
G |
Pex11g |
peroxisomal biogenesis factor 11 gamma |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PEX11G mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:1,502,606...1,532,347
Ensembl chr12:1,503,646...1,512,585
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PGD mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Pheta1 |
PH domain containing endocytic trafficking adaptor 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PHETA1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:34,711,831...34,717,601
Ensembl chr12:34,711,810...34,717,081
|
|
G |
Phtf1 |
putative homeodomain transcription factor 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PHTF1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:191,470,849...191,537,399
Ensembl chr 2:191,473,130...191,512,078
|
|
G |
Pip4k2b |
phosphatidylinositol-5-phosphate 4-kinase type 2 beta |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PIP4K2B mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:82,706,016...82,734,938
Ensembl chr10:82,701,098...82,734,938
|
|
G |
Pir |
pirin |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PIR mRNA |
CTD |
PMID:31734321 |
|
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
|
|
G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PITPNB protein |
CTD |
PMID:21469165 |
|
NCBI chr12:45,249,308...45,298,388
Ensembl chr12:45,249,333...45,298,314
|
|
G |
Piwil2 |
piwi-like RNA-mediated gene silencing 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PIWIL2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
|
|
G |
Pjvk |
pejvakin |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PJVK mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:61,594,644...61,605,051
Ensembl chr 3:61,596,641...61,605,045
|
|
G |
Pla2g4a |
phospholipase A2 group 4A |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PLA2G4A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PLAUR mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Pld1 |
phospholipase D1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PLD1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
|
|
G |
Plekhb1 |
pleckstrin homology domain containing B1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PLEKHB1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:154,998,798...155,013,094
Ensembl chr 1:154,998,800...155,016,142
|
|
G |
Plekhg1 |
pleckstrin homology and RhoGEF domain containing G1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PLEKHG1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:40,348,684...40,434,063
Ensembl chr 1:40,311,221...40,434,063
|
|
G |
Plgrkt |
plasminogen receptor with a C-terminal lysine |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PLGRKT mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:227,099,005...227,111,277
Ensembl chr 1:227,099,015...227,111,194
|
|
G |
Plk3 |
polo-like kinase 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PLK3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
|
|
G |
Plpp3 |
phospholipid phosphatase 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PLPP3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
|
|
G |
Plxnc1 |
plexin C1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PLXNC1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:29,390,048...29,543,779
|
|
G |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PNPLA6 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
|
|
G |
Ppfibp2 |
PPFIA binding protein 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PPFIBP2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:161,504,774...161,687,339
Ensembl chr 1:161,504,890...161,655,212
|
|
G |
Ppif |
peptidylprolyl isomerase F |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PPIF mRNA |
CTD |
PMID:31734321 |
|
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
|
|
G |
Ppp1cb |
protein phosphatase 1 catalytic subunit beta |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PPP1CB protein |
CTD |
PMID:21469165 |
|
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
|
|
G |
Ppp1r10 |
protein phosphatase 1, regulatory subunit 10 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PPP1R10 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr20:2,822,995...2,838,125
Ensembl chr20:2,822,995...2,837,611
|
|
G |
Prdx2 |
peroxiredoxin 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PRDX2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prmt1 |
protein arginine methyltransferase 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PRMT1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:95,458,853...95,468,176
Ensembl chr 1:95,458,850...95,468,345
|
|
G |
Prps2 |
phosphoribosyl pyrophosphate synthetase 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PRPS2 protein |
CTD |
PMID:21469165 |
|
NCBI chr X:26,975,915...27,013,184
Ensembl chr X:26,976,061...27,013,181
|
|
G |
Prr15 |
proline rich 15 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PRR15 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:83,432,002...83,435,582
Ensembl chr 4:83,431,758...83,437,436
|
|
G |
Prr9 |
proline rich 9 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PRR9 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:177,599,483...177,600,849
Ensembl chr 2:177,599,483...177,600,849
|
|
G |
Prrc2a |
proline-rich coiled-coil 2A |
affects response to substance |
ISO |
PRRC2A SNP affects the susceptibility to Sodium Dodecyl Sulfate |
CTD |
PMID:27258892 |
|
NCBI chr20:3,658,391...3,674,143
Ensembl chr20:3,658,695...3,674,130
|
|
G |
Prrg4 |
proline rich and Gla domain 4 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PRRG4 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
|
|
G |
Prss3 |
serine protease 3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PRSS3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:70,203,088...70,206,562
Ensembl chr 4:70,203,088...70,206,562
|
|
G |
Prss8 |
serine protease 8 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PRSS8 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:182,536,229...182,540,745
Ensembl chr 1:182,536,229...182,540,815
|
|
G |
Psma2 |
proteasome 20S subunit alpha 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PSMA2 protein |
CTD |
PMID:21469165 |
|
NCBI chr17:50,554,536...50,564,923
Ensembl chr17:50,551,924...50,564,938
|
|
G |
Psmb10 |
proteasome 20S subunit beta 10 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PSMB10 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
|
|
G |
Psmb9 |
proteasome 20S subunit beta 9 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PSMB9 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
|
|
G |
Psme3 |
proteasome activator subunit 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PSME3 protein |
CTD |
PMID:20332019 |
|
NCBI chr10:86,257,672...86,265,458
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PTGR1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PTGS2 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PTPRZ1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
|
|
G |
Ptx3 |
pentraxin 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PTX3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
|
|
G |
Pxdn |
peroxidasin |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of PXDN mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:46,580,749...46,658,345
Ensembl chr 6:46,580,761...46,658,345
|
|
G |
Pycard |
PYD and CARD domain containing |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of PYCARD protein |
CTD |
PMID:21469165 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rab33a |
RAB33A, member RAS oncogene family |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of RAB33A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr X:127,694,219...127,706,378
Ensembl chr X:127,694,964...127,706,378
|
|
G |
Rab7b |
Rab7b, member RAS oncogene family |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RAB7B mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:43,121,168...43,147,581
Ensembl chr13:43,121,226...43,147,581
|
|
G |
Raet1e |
retinoic acid early transcript 1E |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RAET1E mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:1,662,665...1,664,609
Ensembl chr 1:1,807,644...1,812,755
|
|
G |
Rara |
retinoic acid receptor, alpha |
decreases expression |
EXP |
Sodium Dodecyl Sulfate results in decreased expression of RARA mRNA |
CTD |
PMID:12815608 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RB1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rccd1 |
RCC1 domain containing 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RCCD1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:134,271,870...134,281,556
Ensembl chr 1:134,271,857...134,280,781
|
|
G |
Rdh12 |
retinol dehydrogenase 12 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RDH12 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:98,015,465...98,028,388
Ensembl chr 6:98,015,465...98,028,388
|
|
G |
Repin1 |
replication initiator 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of REPIN1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:77,548,724...77,554,242
Ensembl chr 4:77,548,849...77,554,257
|
|
G |
Rft1 |
RFT1 homolog |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RFT1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr16:5,827,063...5,861,120
Ensembl chr16:5,827,088...5,861,120
|
|
G |
Rgcc |
regulator of cell cycle |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of RGCC mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
|
|
G |
Rgs1 |
regulator of G-protein signaling 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of RGS1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
|
|
G |
Rhbdf1 |
rhomboid 5 homolog 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RHBDF1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:15,406,832...15,419,765
Ensembl chr10:15,406,859...15,419,763
|
|
G |
Rhbdl2 |
rhomboid like 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RHBDL2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:136,037,560...136,081,970
Ensembl chr 5:136,037,305...136,081,969
|
|
G |
Rhno1 |
RAD9-HUS1-RAD1 interacting nuclear orphan 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RHNO1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:161,634,047...161,639,437
Ensembl chr 4:161,634,048...161,639,371
|
|
G |
Rhou |
ras homolog family member U |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RHOU mRNA |
CTD |
PMID:31734321 |
|
NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552
|
|
G |
Rnd1 |
Rho family GTPase 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of RND1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
|
|
G |
Rnf39 |
ring finger protein 39 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of RNF39 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr20:1,604,794...1,610,283
Ensembl chr20:1,604,794...1,610,283
|
|
G |
Rpl22l1 |
ribosomal protein L22 like 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RPL22L1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:111,754,687...111,756,623
Ensembl chr 2:111,754,687...111,756,625
|
|
G |
Rptn |
repetin |
decreases expression increases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RPTN mRNA Sodium Dodecyl Sulfate results in increased expression of RPTN mRNA |
CTD |
PMID:25240866 PMID:31734321 |
|
NCBI chr 2:179,061,768...179,066,056
Ensembl chr 2:179,060,017...179,065,910
|
|
G |
Rwdd2b |
RWD domain containing 2B |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of RWDD2B mRNA |
CTD |
PMID:31734321 |
|
NCBI chr11:26,665,877...26,677,986
Ensembl chr11:26,665,877...26,674,603
|
|
G |
S100a1 |
S100 calcium binding protein A1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of S100A1 mRNA |
CTD |
PMID:25240866 |
|
NCBI chr 2:175,993,922...175,998,765
Ensembl chr 2:175,993,922...175,999,544
|
|
G |
S100a5 |
S100 calcium binding protein A5 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of S100A5 mRNA |
CTD |
PMID:25240866 |
|
NCBI chr 2:176,095,332...176,099,546
Ensembl chr 2:176,097,539...176,099,546
|
|
G |
S100a7a |
S100 calcium binding protein A7A |
increases expression decreases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of S100A7A mRNA Sodium Dodecyl Sulfate results in decreased expression of S100A7A mRNA |
CTD |
PMID:25240866 |
|
NCBI chr 2:176,151,405...176,155,846
Ensembl chr 2:176,151,288...176,156,441
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of S100A9 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
|
|
G |
S100b |
S100 calcium binding protein B |
multiple interactions |
ISO |
Sodium Dodecyl Sulfate results in increased expression of and results in increased secretion of S100B protein |
CTD |
PMID:24451020 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Samd4a |
sterile alpha motif domain containing 4A |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SAMD4A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:20,135,994...20,352,131
Ensembl chr15:20,134,377...20,348,380
|
|
G |
Samd9 |
sterile alpha motif domain containing 9 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of SAMD9 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:31,164,639...31,184,278
Ensembl chr 4:31,164,510...31,184,322
|
|
G |
Sass6 |
SAS-6 centriolar assembly protein |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SASS6 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:204,546,660...204,578,930
Ensembl chr 2:204,546,660...204,578,927
|
|
G |
Satb2 |
SATB homeobox 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SATB2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:58,348,027...58,534,256
Ensembl chr 9:58,350,246...58,530,707
|
|
G |
Saxo2 |
stabilizer of axonemal microtubules 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SAXO2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:136,596,445...136,638,444
Ensembl chr 1:136,623,493...136,638,454
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression increases expression |
EXP ISO |
Sodium Dodecyl Sulfate results in decreased expression of SCD1 mRNA Sodium Dodecyl Sulfate results in increased expression of SCD mRNA |
CTD |
PMID:12815608 PMID:29155129 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sdf2l1 |
stromal cell-derived factor 2-like 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SDF2L1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
|
|
G |
Sec14l1 |
SEC14-like lipid binding 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SEC14L1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:102,319,920...102,367,070
Ensembl chr10:102,319,920...102,367,068
|
|
G |
Sec22c |
SEC22 homolog C, vesicle trafficking protein |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SEC22C mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:121,345,839...121,371,509
Ensembl chr 8:121,350,107...121,370,925
|
|
G |
Sema3a |
semaphorin 3A |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SEMA3A mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:21,282,398...21,754,834
Ensembl chr 4:21,287,982...21,494,432
|
|
G |
Serinc3 |
serine incorporator 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SERINC3 mRNA |
CTD |
PMID:21621594 |
|
NCBI chr 3:152,301,882...152,321,327
Ensembl chr 3:152,301,772...152,321,808
|
|
G |
Serpinb3 |
serpin family B member 3 |
decreases expression increases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of SERPINB3 protein Sodium Dodecyl Sulfate results in increased expression of SERPINB3 mRNA |
CTD |
PMID:20332019 PMID:30806763 |
|
NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682
|
|
G |
Serpine1 |
serpin family E member 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SERPINE1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sertad4 |
SERTA domain containing 4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SERTAD4 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:104,360,307...104,371,064
Ensembl chr13:104,360,307...104,370,546
|
|
G |
Sgms2 |
sphingomyelin synthase 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SGMS2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:219,889,809...219,967,704
Ensembl chr 2:219,893,572...219,967,546
|
|
G |
Sh3bp4 |
SH3-domain binding protein 4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SH3BP4 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:89,660,156...89,739,163
Ensembl chr 9:89,660,156...89,739,163
|
|
G |
Sh3d21 |
SH3 domain containing 21 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SH3D21 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:138,429,180...138,444,540
Ensembl chr 5:138,429,180...138,444,407
|
|
G |
Shroom3 |
shroom family member 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SHROOM3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr14:15,099,415...15,396,832
Ensembl chr14:15,099,423...15,396,915
|
|
G |
Slc20a1 |
solute carrier family 20 member 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SLC20A1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of SLC22A3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
|
|
G |
Slc22a4 |
solute carrier family 22 member 4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SLC22A4 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
|
|
G |
Slc23a2 |
solute carrier family 23 member 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SLC23A2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:119,302,651...119,395,289
Ensembl chr 3:119,302,666...119,460,343
|
|
G |
Slc25a24 |
solute carrier family 25 member 24 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SLC25A24 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:196,761,076...196,799,236
Ensembl chr 2:196,761,274...196,799,231
|
|
G |
Slc25a43 |
solute carrier family 25, member 43 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of SLC25A43 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr X:115,977,437...116,011,789
Ensembl chr X:115,977,510...116,011,205
|
|
G |
Slc27a1 |
solute carrier family 27 member 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SLC27A1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr16:18,278,984...18,300,173
Ensembl chr16:18,278,984...18,296,063
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SLC7A11 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc9a9 |
solute carrier family 9 member A9 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of SLC9A9 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:95,232,889...95,797,262
Ensembl chr 8:95,232,905...95,796,318
|
|
G |
Smoc1 |
SPARC related modular calcium binding 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SMOC1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:100,701,330...100,897,441
Ensembl chr 6:100,701,346...100,862,699
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression increases expression |
EXP ISO |
Sodium Dodecyl Sulfate results in decreased expression of SOD1 mRNA Sodium Dodecyl Sulfate results in decreased expression of SOD1 protein Sodium Dodecyl Sulfate results in increased expression of SOD1 mRNA |
CTD |
PMID:12815608 PMID:21469165 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sox7 |
SRY-box transcription factor 7 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of SOX7 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:38,180,503...38,187,264
Ensembl chr15:38,180,503...38,187,264
|
|
G |
Spink6 |
serine peptidase inhibitor, Kazal type 6 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SPINK6 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr18:36,397,833...36,410,010
Ensembl chr18:36,397,910...36,409,819
|
|
G |
Spink7 |
serine peptidase inhibitor, Kazal type 7 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SPINK7 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr18:56,045,996...56,049,761
Ensembl chr18:56,045,930...56,049,744
|
|
G |
Sprr3 |
small proline-rich protein 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SPRR3 mRNA |
CTD |
PMID:25240866 |
|
NCBI chr 2:178,027,743...178,028,501
Ensembl chr 2:178,027,425...178,029,891
|
|
G |
Sprr4 |
small proline-rich protein 4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SPRR4 mRNA |
CTD |
PMID:25240866 |
|
NCBI chr 2:178,082,466...178,083,125
Ensembl chr 2:178,082,871...178,083,104
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SRXN1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
St6galnac2 |
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ST6GALNAC2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:101,910,220...101,928,412
Ensembl chr10:101,909,971...101,915,008 Ensembl chr10:101,909,971...101,915,008
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
increases phosphorylation multiple interactions |
ISO |
Sodium Dodecyl Sulfate results in increased phosphorylation of STAT6 protein WHI P131 inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of STAT6 protein] |
CTD |
PMID:31734321 |
|
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Stk10 |
serine/threonine kinase 10 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of STK10 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:17,117,860...17,212,065
Ensembl chr10:17,117,878...17,212,061
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of SULT1E1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Sult2b1 |
sulfotransferase family 2B member 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of SULT2B1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:96,200,156...96,261,295
|
|
G |
Susd1 |
sushi domain containing 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SUSD1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:74,157,653...74,281,171
Ensembl chr 5:74,157,773...74,276,291
|
|
G |
Syngr3 |
synaptogyrin 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of SYNGR3 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:13,710,553...13,715,309
Ensembl chr10:13,704,998...13,715,669
|
|
G |
Tac1 |
tachykinin, precursor 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TAC1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Taldo1 |
transaldolase 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of TALDO1 protein |
CTD |
PMID:21469165 |
|
NCBI chr 1:196,493,634...196,503,965
Ensembl chr 1:196,493,589...196,503,974
|
|
G |
Tcf7l2 |
transcription factor 7 like 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TCF7L2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:254,785,956...254,978,967
Ensembl chr 1:254,786,091...254,978,967
|
|
G |
Tert |
telomerase reverse transcriptase |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of TERT mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tex14 |
testis expressed 14, intercellular bridge forming factor |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TEX14 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:72,231,766...72,356,938
Ensembl chr10:72,231,801...72,355,805
|
|
G |
Tex261 |
testis expressed 261 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of TEX261 mRNA |
CTD |
PMID:21621594 |
|
NCBI chr 4:116,253,547...116,260,730
Ensembl chr 4:116,244,600...116,260,253
|
|
G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TFPI2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
|
|
G |
Thnsl1 |
threonine synthase-like 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of THNSL1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr17:83,714,794...83,722,190
Ensembl chr17:83,714,738...83,723,805
|
|
G |
Tlr2 |
toll-like receptor 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TLR2 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tm4sf1 |
transmembrane 4 L six family member 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TM4SF1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:141,456,950...141,466,146
Ensembl chr 2:141,453,310...141,466,146
|
|
G |
Tmem125 |
transmembrane protein 125 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TMEM125 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:132,063,162...132,064,566
Ensembl chr 5:132,059,554...132,079,297 Ensembl chr 5:132,059,554...132,079,297
|
|
G |
Tmem177 |
transmembrane protein 177 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of TMEM177 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
|
|
G |
Tmem45b |
transmembrane protein 45b |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of TMEM45B mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:29,865,276...29,910,453
Ensembl chr 8:29,865,278...29,910,453
|
|
G |
Tnc |
tenascin C |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TNC mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
|
|
G |
Tnf |
tumor necrosis factor |
increases expression affects expression multiple interactions increases secretion |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TNF mRNA Sodium Dodecyl Sulfate affects the expression of TNF mRNA Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein] Sodium Dodecyl Sulfate results in increased secretion of TNF protein |
CTD |
PMID:9856837 PMID:15679580 PMID:20385217 PMID:31734321 PMID:36416909 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:20146380 PMID:31734321 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of TNFAIP6 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Traf4 |
Tnf receptor associated factor 4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TRAF4 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
|
|
G |
Trim6 |
tripartite motif containing 6 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of TRIM6 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:158,683,746...158,696,936
Ensembl chr 1:158,683,746...158,696,914
|
|
G |
Trmt12 |
tRNA methyltransferase 12 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of TRMT12 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:90,417,846...90,419,472
Ensembl chr 7:90,417,862...90,419,867
|
|
G |
Tsen54 |
tRNA splicing endonuclease subunit 54 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TSEN54 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:101,041,607...101,050,088
Ensembl chr10:101,042,503...101,050,087
|
|
G |
Ttc32 |
tetratricopeptide repeat domain 32 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TTC32 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 6:31,834,428...31,841,027
Ensembl chr 6:31,834,428...31,842,621
|
|
G |
Txn1 |
thioredoxin 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TXN mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of TXNRD1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Tymp |
thymidine phosphorylase |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of TYMP mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
|
|
G |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of UBE2E2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:6,980,241...7,257,912
Ensembl chr15:6,980,474...7,257,532
|
|
G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of UHRF1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
|
|
G |
Ulk4 |
unc-51 like kinase 4 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ULK4 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:120,670,879...120,966,026
Ensembl chr 8:120,670,866...120,966,924
|
|
G |
Usp43 |
ubiquitin specific peptidase 43 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of USP43 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:52,549,200...52,611,168
Ensembl chr10:52,548,963...52,611,533
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of VEGFA mRNA; Sodium Dodecyl Sulfate results in increased expression of VEGFA protein |
CTD |
PMID:9390328 PMID:25617811 PMID:31734321 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfc |
vascular endothelial growth factor C |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of VEGFC mRNA |
CTD |
PMID:25617811 |
|
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
|
|
G |
Vegfd |
vascular endothelial growth factor D |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of VEGFD mRNA |
CTD |
PMID:20146380 |
|
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
|
|
G |
Vmp1 |
vacuole membrane protein 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of VMP1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr10:71,405,058...71,505,045
Ensembl chr10:71,405,452...71,505,007
|
|
G |
Vps29 |
VPS29 retromer complex component |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of VPS29 protein |
CTD |
PMID:21469165 |
|
NCBI chr12:34,208,911...34,217,977
Ensembl chr12:34,207,263...34,217,964
|
|
G |
Vta1 |
vesicle trafficking 1 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of VTA1 protein |
CTD |
PMID:21469165 |
|
NCBI chr 1:9,032,861...9,080,635
Ensembl chr 1:9,032,335...9,080,635
|
|
G |
Vwce |
von Willebrand factor C and EGF domains |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of VWCE mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:207,280,714...207,327,215
Ensembl chr 1:207,282,356...207,312,986
|
|
G |
Wdr5b |
WD repeat domain 5B |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of WDR5B mRNA |
CTD |
PMID:31734321 |
|
NCBI chr11:64,710,945...64,712,804
Ensembl chr11:64,710,355...64,712,807
|
|
G |
Yod1 |
YOD1 deubiquitinase |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of YOD1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr13:42,175,047...42,181,661
Ensembl chr13:42,174,820...42,177,205
|
|
G |
Zbtb26 |
zinc finger and BTB domain containing 26 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ZBTB26 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:21,195,319...21,207,925
Ensembl chr 3:21,195,319...21,207,942
|
|
G |
Zc3h13 |
zinc finger CCCH type containing 13 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ZC3H13 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr15:50,607,335...50,671,802
Ensembl chr15:50,607,380...50,671,802
|
|
G |
Zc3h8 |
zinc finger CCCH type containing 8 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ZC3H8 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 3:116,176,779...116,193,752
Ensembl chr 3:116,176,798...116,193,787
|
|
G |
Zc3hav1 |
zinc finger CCCH-type containing, antiviral 1 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ZC3HAV1 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:67,012,129...67,062,428
Ensembl chr 4:67,012,185...67,062,428
|
|
G |
Zc3hav1l |
zinc finger CCCH-type containing, antiviral 1 like |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ZC3HAV1L mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 4:66,994,192...67,003,207
Ensembl chr 4:66,994,199...67,001,620
|
|
G |
Zdhhc23 |
zinc finger DHHC-type palmitoyltransferase 23 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ZDHHC23 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr11:56,718,702...56,735,063
Ensembl chr11:56,718,826...56,734,194
|
|
G |
Zfp12 |
zinc finger protein 12 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ZNF12 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr12:11,316,971...11,330,498
Ensembl chr12:11,316,872...11,330,558
|
|
G |
Zfp185 |
zinc finger protein 185 |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ZNF185 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr X:150,831,869...150,877,652
Ensembl chr X:150,831,862...150,874,810
|
|
G |
Zfp57 |
zinc finger protein 57 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ZFP57 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr20:1,521,323...1,534,884
Ensembl chr20:1,521,323...1,529,846
|
|
G |
Zfp780b |
zinc finger protein 780B |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of KRBOX5 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 1:83,058,993...83,182,629
Ensembl chr 1:83,160,399...83,183,254 Ensembl chr 1:83,160,399...83,183,254 Ensembl chr 1:83,160,399...83,183,254
|
|
G |
Zmiz2 |
zinc finger, MIZ-type containing 2 |
increases expression |
ISO |
Sodium Dodecyl Sulfate results in increased expression of ZMIZ2 mRNA |
CTD |
PMID:31734321 |
|
NCBI chr14:81,251,391...81,267,936
Ensembl chr14:81,251,417...81,267,936
|
|
G |
Zwilch |
zwilch kinetochore protein |
decreases expression |
ISO |
Sodium Dodecyl Sulfate results in decreased expression of ZWILCH mRNA |
CTD |
PMID:31734321 |
|
NCBI chr 8:64,638,401...64,670,911
Ensembl chr 8:64,637,672...64,675,916
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; [sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Dizocilpine Maleate inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; KT 5720 inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein] |
CTD |
PMID:21873648 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
decreases expression |
EXP |
sodium bisulfite results in decreased expression of COX4 mRNA |
CTD |
PMID:26980303 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
decreases expression |
EXP |
sodium bisulfite results in decreased expression of ATP6 mRNA |
CTD |
PMID:26980303 |
|
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of ATP8 mRNA] |
CTD |
PMID:26980303 |
|
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of COX1 mRNA] |
CTD |
PMID:26980303 |
|
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
decreases expression |
EXP |
sodium bisulfite results in decreased expression of COX2 mRNA |
CTD |
PMID:26980303 |
|
NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
|
|
G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
multiple interactions decreases expression |
EXP |
TFAM protein inhibits the reaction [sodium bisulfite results in decreased expression of COX3 mRNA] |
CTD |
PMID:26980303 |
|
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
sodium bisulfite inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA] |
CTD |
PMID:25086357 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of NRF1 mRNA] sodium bisulfite results in decreased expression of NRF1 mRNA; sodium bisulfite results in decreased expression of NRF1 protein |
CTD |
PMID:26980303 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of PPARGC1A mRNA] sodium bisulfite results in decreased expression of PPARGC1A mRNA; sodium bisulfite results in decreased expression of PPARGC1A protein |
CTD |
PMID:26980303 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
multiple interactions |
EXP |
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER2 protein |
CTD |
PMID:21873648 |
|
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
multiple interactions |
EXP |
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER4 protein |
CTD |
PMID:21873648 |
|
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptges |
prostaglandin E synthase |
multiple interactions |
EXP |
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES mRNA |
CTD |
PMID:21873648 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptges2 |
prostaglandin E synthase 2 |
multiple interactions |
EXP |
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES2 mRNA |
CTD |
PMID:21873648 |
|
NCBI chr 3:15,690,501...15,697,688
Ensembl chr 3:15,690,501...15,697,688
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
EXP |
[SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]] |
CTD |
PMID:21873648 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP ISO |
[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Cyclic AMP]; [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]; [SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]]; [sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein] sodium bisulfite inhibits the reaction [Rotenone results in increased expression of PTGS2 mRNA]; sodium bisulfite inhibits the reaction [Rotenone results in increased expression of PTGS2 protein] |
CTD |
PMID:21873648 PMID:25086357 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Tfam |
transcription factor A, mitochondrial |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of TFAM mRNA]; TFAM protein inhibits the reaction [sodium bisulfite results in decreased expression of COX3 mRNA] sodium bisulfite results in decreased expression of TFAM mRNA; sodium bisulfite results in decreased expression of TFAM protein |
CTD |
PMID:26980303 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
sodium bisulfite inhibits the reaction [Rotenone results in increased expression of TNF mRNA] |
CTD |
PMID:25086357 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
EXP |
sodium selenate inhibits the reaction [3,3',4,4',5-pentachlorobiphenyl, PCB-126, increases expression of mRNA] in rat liver |
RGD |
PMID:23644946 |
RGD:401794573 |
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Apoa1 |
apolipoprotein A1 |
multiple interactions |
EXP |
sodium selenate inhibits the reaction [3,3',4,4',5-pentachlorobiphenyl, PCB-126, increases expression of mRNA] in rat liver |
RGD |
PMID:23644946 |
RGD:401794573 |
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
sodium selenate inhibits the reaction [3,3',4,4',5-pentachlorobiphenyl, PCB-126, increases expression of mRNA] in rat liver |
RGD |
PMID:23644946 |
RGD:401794573 |
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions |
EXP |
sodium selenate inhibits the reaction [3,3',4,4',5-pentachlorobiphenyl, PCB-126, increases expression of mRNA] in rat liver |
RGD |
PMID:23644946 |
RGD:401794573 |
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
[NOS1 co-treated with sodium sulfite co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased oxidation of ALB protein |
CTD |
PMID:20348042 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; [sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Dizocilpine Maleate inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; KT 5720 inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein] |
CTD |
PMID:21873648 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases export |
ISO |
sodium sulfite results in increased export of GPT protein |
CTD |
PMID:23973939 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
ISO |
[NOS1 co-treated with sodium sulfite co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased oxidation of ALB protein |
CTD |
PMID:20348042 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
multiple interactions |
EXP |
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER2 protein |
CTD |
PMID:21873648 |
|
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
multiple interactions |
EXP |
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER4 protein |
CTD |
PMID:21873648 |
|
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptges |
prostaglandin E synthase |
multiple interactions |
EXP |
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES mRNA |
CTD |
PMID:21873648 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptges2 |
prostaglandin E synthase 2 |
multiple interactions |
EXP |
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES2 mRNA |
CTD |
PMID:21873648 |
|
NCBI chr 3:15,690,501...15,697,688
Ensembl chr 3:15,690,501...15,697,688
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
EXP |
[SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]] |
CTD |
PMID:21873648 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Cyclic AMP]; [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]; [SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]]; [sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein] |
CTD |
PMID:21873648 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
increases expression |
ISO |
sodium sulfite results in increased expression of RIPK1 protein |
CTD |
PMID:23973939 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
|
G |
Il17a |
interleukin 17A |
increases expression |
EXP |
Sodium taurocholate increases expression of Il17a mRNA and protein in the pancreas |
RGD |
PMID:22990529 |
RGD:9068935 |
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
EXP |
taurocholate decreased activity of Serpinf1 protein in plasma |
RGD |
PMID:10360224 |
RGD:8661651 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein] |
CTD |
PMID:32865837 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of CASP9 protein] |
CTD |
PMID:32865837 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of MPO protein] |
CTD |
PMID:32865837 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCB1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCB4 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ABCC1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC2 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC3 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ABCC4 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG2 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG5 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG8 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ADGRG1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH1C mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH4 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adh6 |
alcohol dehydrogenase 6 (class V) |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534
|
|
G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR1D1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A3 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ALB mRNA |
CTD |
PMID:33819548 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of AMPD3 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
|
|
G |
Apoa1 |
apolipoprotein A1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of APOA1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ATP8B1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of BAAT mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BACH1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BCL2L1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
[Tartrazine co-treated with Erythrosine] affects the expression of CASP9 mRNA |
CTD |
PMID:32981412 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases activity multiple interactions |
EXP ISO |
Tartrazine results in decreased activity of CAT protein [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CAT mRNA |
CTD |
PMID:20678534 PMID:33819548 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
EXP |
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of CHRNA4 protein |
CTD |
PMID:23429044 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
EXP |
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of CHRNB2 protein |
CTD |
PMID:23429044 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Csf1 |
colony stimulating factor 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of CSF1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2B6 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2C18 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A5 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7B1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC10 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
|
|
G |
Dnajc18 |
DnaJ heat shock protein family (Hsp40) member C18 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC18 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr18:27,269,350...27,303,453
Ensembl chr18:27,269,355...27,298,344
|
|
G |
Dnajc9 |
DnaJ heat shock protein family (Hsp40) member C9 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr15:3,923,842...3,928,118
Ensembl chr15:3,923,268...3,928,118
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Esr1 |
estrogen receptor 1 |
increases activity multiple interactions |
ISO |
Tartrazine results in increased activity of ESR1 protein fulvestrant inhibits the reaction [Tartrazine results in increased activity of ESR1 protein] |
CTD |
PMID:22562034 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of FMO1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of FTH1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GCLM mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GJB2 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gprc5b |
G protein-coupled receptor, class C, group 5, member B |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GPRC5B mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
multiple interactions |
EXP |
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein |
CTD |
PMID:23429044 |
|
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA4 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTT1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
EXP |
[Tartrazine co-treated with Erythrosine] affects the expression of HAVCR1 mRNA |
CTD |
PMID:32981412 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hpx |
hemopexin |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of HPX mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IFI27 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IL1R1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of JUN mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of JUN mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lipc |
lipase C, hepatic type |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of LIPC mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Ly96 |
lymphocyte antigen 96 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
|
|
G |
Maf |
MAF bZIP transcription factor |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAF mRNA |
CTD |
PMID:33819548 |
|
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
|
|
G |
Maff |
MAF bZIP transcription factor F |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAFF mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP2K2 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAP2K6 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
|
|
G |
Mapkapk3 |
MAPK activated protein kinase 3 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 8:107,929,754...107,963,638
Ensembl chr 8:107,929,762...107,963,568
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MGST1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Mlkl |
mixed lineage kinase domain like pseudokinase |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MLKL mRNA |
CTD |
PMID:33819548 |
|
NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502
|
|
G |
Mmut |
methylmalonyl-CoA mutase |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MMUT mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MTTP mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR0B2 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1H4 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1I2 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1I3 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Pah |
phenylalanine hydroxylase |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PAH mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
|
|
G |
Pik3c2a |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PIK3C2A mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:170,577,942...170,684,353
Ensembl chr 1:170,577,942...170,683,472
|
|
G |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PIK3C2G mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 4:172,483,752...172,851,623
Ensembl chr 4:172,484,345...172,850,544
|
|
G |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PIK3R3 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
|
|
G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PPP1R3C mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
|
|
G |
Prkd3 |
protein kinase D3 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PRKD3 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 6:16,032,507...16,108,444
Ensembl chr 6:16,032,585...16,108,443
|
|
G |
Rara |
retinoic acid receptor, alpha |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of RARA mRNA |
CTD |
PMID:33819548 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rasd1 |
ras related dexamethasone induced 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of RASD1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
|
|
G |
Rdh16 |
retinol dehydrogenase 16 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of RDH16 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 7:63,616,711...63,625,053
Ensembl chr 7:63,597,536...63,624,124
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of SERPINE1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLC10A1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLC22A1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of SOD2 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sorl1 |
sortilin related receptor 1 |
multiple interactions |
ISO |
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SORL1 mRNA |
CTD |
PMID:33819548 |
|
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
|
| |